# Astellas Pharma Inc., Takaoka, Japan – FDA Inspections

Source: https://www.keypedia.com/companies/astellas-pharma-inc/ad5c1a7d-23cf-412a-88ce-62ab257c3233

> Inspection records and compliance data for Astellas Pharma Inc. in Takaoka. 6 FDA inspections on record, 2 Form 483s, last inspected June 06, 2025.

---

## Details

- Name: Astellas Pharma Inc.
- FEI Number: 3002807001
- Address Line 1: 30, Toidesakaemachi
- City: Takaoka
- Country Name: Japan
- Address: 30, Toidesakaemachi, Takaoka, Japan
- Country: Japan

## Related Documents

- [FDA Inspection 1274944 - Astellas Pharma Inc. - 2025-06-06](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/dd27836e-06a5-4845-980e-a356aeaafacc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 6, 2025
- [483 - Astellas Pharma Inc. - 2025-06-02](https://www.keypedia.com/records/483/astellas-pharma-inc/0e777650-afc9-4c07-a188-8487371da7f8) — source: FDA, date: June 2, 2025
- Canada Inspection - Astellas Pharma Inc. - Inspection #82317 - 2023-12-06 — source: Canada, date: December 6, 2023
- [483 - Astellas Pharma Inc. - 2019-03-05](https://www.keypedia.com/records/483/astellas-pharma-inc/bc58294a-3a70-44de-9115-dcad18a40e5f) — source: FDA, date: March 5, 2019
- [FDA Inspection 1081668 - Astellas Pharma Inc. - 2019-03-05](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/a24c61dd-8240-493f-bad1-7c0abd0c4f4c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 5, 2019
- FDA Inspection 963371 - Astellas Pharma Inc. - 2016-03-18 — classification: No Action Indicated (NAI), source: FDA, date: March 18, 2016
- [FDA Inspection 874760 - Astellas Pharma Inc. - 2014-04-11](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/f2164931-62b5-469c-a796-70010506df65) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 11, 2014
- FDA Inspection 756552 - Astellas Pharma Inc. - 2011-11-21 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2011
- [FDA Inspection 548559 - Astellas Pharma Inc. - 2008-11-07](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/f2647247-4f2e-4543-b111-52cad2d1e7e2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 7, 2008

## Related Companies

- [Vetter Pharma Fertigung GmbH & Co. KG](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg/9c78f7c1-8016-4128-9dc3-ce5b4e0e0d44)
- [Chugai Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/chugai-pharmaceutical-co-ltd/5261bb2e-233a-40e3-8aa3-3e7b0b70dd29)
- [Nippon Fine Chemical Co., Ltd.](https://www.keypedia.com/companies/nippon-fine-chemical-co-ltd/6b21c73b-4779-42c3-b0f6-64179f8de3a2)
- [Shionogi Pharma Co., Ltd.](https://www.keypedia.com/companies/shionogi-pharma-co-ltd/97a7893d-fd4c-45bc-9237-0e03e7d8af7c)
- [Nang Kuang Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/nang-kuang-pharmaceutical-co-ltd/bdb8b0bb-4a8d-4f50-a72d-e250626e2818)
- [Quotient Sciences - Philadelphia, LLC](https://www.keypedia.com/companies/quotient-sciences-philadelphia-llc/21968347-fe31-4ffc-801c-5253fa909968)
- [Cardinal Health 414, LLC](https://www.keypedia.com/companies/cardinal-health-414-llc/b1d6d59b-695c-42a4-8272-d3e5a96de306)
- [Iso-Tex Diagnostics, Inc.](https://www.keypedia.com/companies/iso-tex-diagnostics-inc/59c59676-32cc-4749-b95d-3bdc31559b58)
- [SpecGx, LLC](https://www.keypedia.com/companies/specgx-llc/ee069c18-3128-4bbe-9c13-768b4837810f)
- [Sun Pharmaceuticals Industries Ltd.](https://www.keypedia.com/companies/sun-pharmaceuticals-industries-ltd/758af0ba-71ed-4144-b6c7-e175eaafa473)

## Related Officers

- [Dedicated Device Cadre](https://www.keypedia.com/people/dedicated-device-cadre/693932db-dd86-453f-9b51-a63444b07281)
- [Jose A. Cruz Gonzalez](https://www.keypedia.com/people/jose-a-cruz-gonzalez/a005cff1-0a90-4396-82c4-de4b0a579374)
- [Bijoy Panicker](https://www.keypedia.com/people/bijoy-panicker/1c6ec57f-e02e-49b8-8b59-1853f3d2947a)